Efficacy and Safety of Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke Combined With Type 2 Diabetes Mellitus

NCT06085378 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

630

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke
Type 2 Diabetes

Interventions

DRUG: Urinary Kallidinogenase for injection
OTHER: Placebo

Sponsor

First Affiliated Hospital, Sun Yat-Sen University